Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study
详细信息查看全文 | 推荐本文 |
摘要

Background

We previously described a composite MRI scale combining T1-lesions, T2-lesions and whole brain atrophy in multiple sclerosis (MS): the magnetic resonance disease severity scale (MRDSS).

Objective

Test strength of the MRDSS vs. individual MRI measures for sensitivity to longitudinal change.

Methods

We studied 84 MS patients over a 3.2 卤 0.3 year follow-up. Baseline and follow-up T2-lesion volume (T2LV), T1-hypointense lesion volume (T1LV), and brain parenchymal fraction (BPF) were measured. MRDSS was the combination of standardized T2LV, T1/T2 ratio and BPF.

Results

Patients had higher MRDSS at follow-up vs. baseline (p < 0.001). BPF decreased (p < 0.001), T1/T2 increased (p < 0.001), and T2LV was unchanged (p > 0.5). Change in MRDSS was larger than the change in MRI subcomponents. While MRDSS showed significant change in relapsing-remitting (RR) (p < 0.001) and secondary progressive (SP) phenotypes (p < 0.05), BPF and T1/T2 ratio changed only in RRMS (p < 0.001). Longitudinal change in MRDSS was significantly different between RRMS and SPMS (p = 0.0027); however, change in the individual MRI components did not differ. Evaluation with respect to predicting on-study clinical worsening as measured by EDSS revealed a significant association only for T2LV (p = 0.038).

Conclusion

Results suggest improved sensitivity of MRDSS to longitudinal change vs. individual MRI measures. MRDSS has particularly high sensitivity in RRMS.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700